Legend Biotech Corp - ADR Forecast, price target & analysts
Legend Biotech Corp - ADR Target price 2025 - Analyst rating & recommendation
Legend Biotech Corp - ADR Classifications & Recommendation:
Legend Biotech Corp - ADR Price Target
| Target Price | $79.56 |
| Price | $34.63 |
| Potential |
129.74%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target Legend Biotech Corp - ADR 2026 .
The average Legend Biotech Corp - ADR target price is $79.56.
This is
129.74%
register free of charge
$99.75
188.05%
register free of charge
$53.65
54.93%
register free of charge
|
|
| A rating was issued by 30 analysts: 27 Analysts recommend Legend Biotech Corp - ADR to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Legend Biotech Corp - ADR stock has an average upside potential 2026 of
129.74%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 627.24 | 1,038.00 |
| 119.98% | 65.49% | |
| EBITDA Margin | -44.93% | -12.91% |
| 74.76% | 71.26% | |
| Net Margin | -28.22% | -22.13% |
| 84.47% | 21.59% |
25 Analysts have issued a sales forecast Legend Biotech Corp - ADR 2025 . The average Legend Biotech Corp - ADR sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Legend Biotech Corp - ADR EBITDA forecast 2025. The average Legend Biotech Corp - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Legend Biotech Corp - ADR Analysts have issued a net profit forecast 2025. The average Legend Biotech Corp - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.48 | -0.62 |
| 67.35% | 29.17% | |
| P/E | negative | |
| EV/Sales | 5.32 |
22 Analysts have issued a Legend Biotech Corp - ADR forecast for earnings per share. The average Legend Biotech Corp - ADR EPS is
This results in the following potential growth metrics and future valuations:
Legend Biotech Corp - ADR...
Current Legend Biotech Corp - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | May 14 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | May 14 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 22 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 17 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
May 14 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 14 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 22 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 17 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 12 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
